文献速递眼底病与葡萄膜炎

ANRIL:糖尿病视网膜病变中VEGF的调节因子

ANRIL: A Regulator of VEGF in Diabetic Retinopathy.
PubMed 文献 · Invest Ophthalmol Vis Sci · 2017-01-01

该研究在体外高糖培养的人视网膜内皮细胞和体内链脲佐菌素诱导的糖尿病ANRIL敲除小鼠中,探讨长链非编码RNA ANRIL对血管内皮生长因子(VEGF)的调控。结果显示高糖和糖尿病使ANRIL上调,沉默ANRIL可阻止VEGF表达,该调控涉及PRC2组分p300、miR200b和EZH2。

要点

  • 高糖和糖尿病导致人视网膜内皮细胞及视网膜中ANRIL上调。
  • 沉默ANRIL可阻止葡萄糖介导的VEGF表达升高。
  • ANRIL对VEGF的调控涉及PRC2组分p300、miR200b和EZH2。

核心结论

  • 结果首次证明ANRIL在糖尿病视网膜病变中调节VEGF表达和功能,该调控由PRC2复合物的p300、miR200b和EZH2介导。

研究设计与样本

  • 体外研究:人视网膜内皮细胞(HRECs)高糖孵育模拟糖尿病,并行小干扰RNA(siRNA)敲低ANRIL。
  • 体内研究:ANRIL敲除小鼠,伴或不伴链脲佐菌素诱导的糖尿病。
  • 检测VEGF mRNA和蛋白表达,并通过管腔形成、细胞增殖和视网膜血管通透性实验评估VEGF功能改变。

主要发现

  • 高糖和糖尿病导致HRECs和视网膜中ANRIL上调。
  • 沉默葡萄糖介导升高的ANRIL可阻止VEGF表达。
  • 该调控涉及ANRIL对PRC2组分p300和miR200b的控制。
  • 高糖暴露后ANRIL与p300及EZH2(PRC2组分)的直接结合增加。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Long noncoding RNAs (lncRNAs) previously thought to be "dark matter" of the genome, play key roles in various biological processes. The lncRNA ANRIL is located at a genetic susceptibility locus for coronary artery diseases and type 2 diabetes. We examined the role of ANRIL in diabetic retinopathy, through study of its regulation of VEGF both in vitro and in vivo. METHODS: Human retinal endothelial cells (HRECs) were subjected to incubation in high glucose to mimic diabetes. ANRIL expression was measured with or without small interfering RNA (siRNA) knockdown in HRECs. ANRIL knockout mice, with or without streptozotocin-induced diabetes, were also investigated. Cell and tissues were measured for VEGF mRNA and protein expression. Functional alterations in VEGF were determined through tube formation, cell proliferation, and retinal vascular permeability assays. Vascular endothelial growth factor regulation through ANRIL's interactions with polycomb repressive complex 2 (PRC2) components and p300 were studied thorough PRC2 blocker, siRNA, and RNA immunoprecipitation (RNA-IP) assays. RESULTS: High glucose and diabetes caused ANRIL upregulation in HRECs and in the retina. Glucose-mediated elevation of ANRIL, on silencing, prevented VEGF expression. Such regulation involved ANRIL-mediated control of the PRC2 components p300 and miR200b. Direct binding of ANRIL to p300 and enhancer of zeste homolog 2 (EZH2; a PRC2 component) were elevated following exposure to high glucose levels. CONCLUSIONS: Our results demonstrate for the first time that ANRIL regulates VEGF expression and function in diabetic retinopathy. This regulation is mediated by p300, miR200b, and EZH2 of the PRC2 complex.

来源:Invest Ophthalmol Vis Sci,查看原文。版权归原作者所有。

引用

  1. Thomas AA, Feng B, Chakrabarti S, et al. ANRIL: A Regulator of VEGF in Diabetic Retinopathy. Invest Ophthalmol Vis Sci. 2017. PMID: 28122089. doi:10.1167/iovs.16-20569

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。